| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10917947 | Radiotherapy and Oncology | 2015 | 6 Pages |
Abstract
This trial confirmed that the oral administration of EGCG is an effective and safe method to deal with ARIE. A phase III randomized controlled trial is expected to further corroborate the consequence of EGCG in ARIE treatment.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Hanxi Zhao, Peng Xie, Xiaolin Li, Wanqi Zhu, Xindong Sun, Xiaorong Sun, Xiaoting Chen, Ligang Xing, Jinming Yu,